Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Natures
  • Helianthus
    (1)
TargetMol | Tags By Target
  • IL Receptor
    (2)
  • Antibacterial
    (1)
  • Antibiotic
    (1)
  • Antifungal
    (1)
  • Apoptosis
    (1)
  • COX
    (1)
  • Endogenous Metabolite
    (1)
  • Immunology/Inflammation related
    (1)
  • MAPK
    (1)
  • Others
    (7)
TargetMol | Tags By ResearchField
  • Cancer
    (7)
  • Inflammation
    (1)
  • Metabolism
    (1)
TargetMol | Tags By Application
  • ELISA
    (2)
  • FCM
    (2)
  • Functional assay
    (2)
Filter
Search Result
Results for "

cervical carcinoma cells

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    14
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    10
    TargetMol | Natural_Products
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
  • Reference Standards
    2
    TargetMol | Standard_Products
β-Aminopropionitrile
BAPN, 3-Aminopropionitrile
T13475151-18-8
β-Aminopropionitrile (3-Aminopropionitrile) is a selective inhibitor of lysyl oxidase.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Ganoderic acid F
T1136398665-15-7
Ganoderic acid F exhibits antitumor and antimetastatic activities through inhibition of angiogenesis and alteration of proteins involving cell proliferation and/or cell death, carcinogenesis, oxidative stress, calcium signaling, and endoplasmic reticulum
  • $98
In Stock
Size
QTY
Ganoderic acid D
T5S1133108340-60-9
1. Ganoderic acid D is one of the major components in Ganoderma triterpenes. 2. Ganoderic acid D treatment for 48h inhibits the proliferation of HeLa human cervical carcinoma cells with an IC(5) value of 17.3 +/- .3 microM.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
B-Raf IN 7
T609332477725-07-6
B-Raf IN 7 (compound 6a) is a potent B-Raf inhibitor with an IC50 of 110.23 nM. It exhibits antitumor activity against colon carcinoma cells (HCT-116), mammary gland cells (MCF-7), hepatocellular carcinoma cells (HEPG-2), human cervical carcinoma cells (Hela), and human prostate cancer cells (PC-3), with IC50 values of 7.50, 9.87, 10.57, 11.63, and 12.83 μM, respectively [1].
  • $1,520
6-8 weeks
Size
QTY
BPR1K653
T712791192754-07-6
BPR1K653 is a potent Aurora kinase inhibitor with potential anticancder activity. BPR1K653 specifically inhibited the activity of Aurora-A and Aurora-B kinase at low nano-molar concentrations in vitro. BPR1K653 was potent in targeting a variety of cancer cell lines regardless of the tissue origin, p53 status, or expression of MDR1. At the cellular level, BPR1K653 induced endo-replication and subsequent apoptosis in both MDR1-negative and MDR1-positive cancer cells. Importantly, it showed potent activity against the growth of xenograft tumors of the human cervical carcinoma KB and KB-derived MDR1-positive KB-VIN10 cells in nude mice. Finally, BPR1K653 also exhibited favorable pharmacokinetic properties in rats., BPR1K653 is a promising anti-cancer compound that has potential for the management of various malignancies, particularly for patients with MDR1-related drug resistance after prolonged chemotherapeutic treatments.
  • $1,520
6-8 weeks
Size
QTY
Cadonilimab
BTG502
T767162394841-59-7
Cadonilimab (AK104) is a tetravalent PD-1/CTLA-4 bispecific humanised antibody that activates T cells by enhancing IL-2 and IFN-γ secretion while reducing pro-inflammatory cytokine secretion (e.g., IL-6, IL-8). It offers low toxicity and high affinity, making it suitable for metastatic cervical, gastric, hepatic, and pulmonary cancers, pancreatic cancer, and oesophageal squamous cell carcinoma.
  • $373
In Stock
Size
QTY
Lirilumab
ONO-4483, IPH2102
T774231000676-41-4
Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-κB deinhibition. It can be used to study leukemia, head and neck squamous cell carcinoma (SCCHN).
  • $183
In Stock
Size
QTY
Ganoderic acid S1
TMA1008104759-35-5
A novel combination of triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS), the composition is suitable for the treatment or prophylaxis of colon ca
  • $660
Inquiry
Size
QTY
Ganoderic acid D (Standard)
TMSM-2443108340-60-9
Ganoderic acid D (Standard) is a reference standard for research and analysis in studies involving Ganoderic acid D. 1. Ganoderic acid D is one of the major components in Ganoderma triterpenes. 2. Ganoderic acid D treatment for 48h inhibits the proliferation of HeLa human cervical carcinoma cells with an IC(5) value of 17.3 +/- .3 microM.
  • $1,090
7-10 days
Size
QTY
Ganoderic acid F (Standard)
TMSM-244498665-15-7
Ganoderic acid F (Standard) is a reference standard for research and analysis in studies involving Ganoderic acid F. Ganoderic acid F inhibits the proliferation of HeLa human cervical carcinoma cells with IC(50) values of 19.5+/-0.6 microM.
  • $1,090
7-10 days
Size
QTY
Ganoderic acid AM1
TN4102149507-55-1
Ganoderic acid AM1 treatment for 48 h inhibited the proliferation of HeLa human cervical carcinoma cells with IC(50) values of 19.8+/-0.7 microM.
  • $760
Inquiry
Size
QTY
Heliangin
TN419413323-48-3
Heliangin shows anti-inflammatory effects, it can inhibit lipopolysaccharide-induced inflammation through signaling NF-κB pathway on LPS-induced RAW 264.7 cells. Heliangin has anti-cancer activity, it exhibits cytotoxicity against human oral epidermoid (
  • $1,800
Inquiry
Size
QTY
Albiducin A
TN90702222286-14-6
Albiducin A is an antibiotic discovered in Hymenoscyphus albidus, possessing both antibacterial and anticancer properties. Its minimum inhibitory concentration (MIC) against bacteria and fungi ranges from 16.7 to 66.7 mg/mL. The IC50 values for mouse fibroblasts (L929) and human cervical carcinoma cells (KB3-1) are 6.1 and 2.7 μg/mL, respectively. Albiducin A shows potential for research in the fields of infectious and cancer diseases.
  • Inquiry Price
Inquiry
Size
QTY
Nocapyrone Q
TN91631558013-79-8
Nocapyrone Q is a polyketide compound identified in the karst cave mold Streptomyces sp. FD-2-6. At a concentration of 100 μM, Nocapyrone Q shows inhibitory activity against human hepatocellular carcinoma HepG2 cells and human cervical cancer HeLa cells. Nocapyrone Q holds potential for research in the field of anticancer studies.
  • Inquiry Price
Inquiry
Size
QTY